Quinapril (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Quinapril drug offered from Aurobindo Pharma Limited. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
NON-PROPRIETARY NAME: | Quinapril Hydrochloride |
SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-04-29 |
END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
Item Description | Quinapril from Aurobindo Pharma Limited |
LABELER NAME: | Aurobindo Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2013-04-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65862-617_bf3a014a-6b9d-4661-a8fd-38be0cda902d |
PRODUCT NDC: | 65862-617 |
APPLICATION NUMBER: | ANDA202725 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: